Publicaciones en colaboración con investigadores/as de Universidad Europea de Madrid (25)

2024

  1. Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain

    HIV Medicine

2023

  1. Corrigendum to “Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)” (EBioMedicine (2020) 55, (S2352396420301547), (10.1016/j.ebiom.2020.102779))

    eBioMedicine

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 3, pp. 738-742

  3. Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study

    BMC Infectious Diseases, Vol. 21, Núm. 1

2020

  1. Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)

    EBioMedicine, Vol. 55

  2. Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study

    AIDS Research and Therapy, Vol. 17, Núm. 1

  3. How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain

    HIV Medicine, Vol. 21, Núm. 2, pp. 128-134

2019

  1. Predictive factors of hepatitis C virus eradication after interferon-free therapy in HIV coinfection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 4, pp. 725-734

2016

  1. Toward a comprehensive care of HIV patients: finding a strategy to detect depression in a Spanish HIV cohort

    AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 28, Núm. 7, pp. 834-841

2014

  1. A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretrovirals

    Clinical Infectious Diseases, Vol. 59, Núm. 11, pp. 1627-1634

2013

  1. Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?

    AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 25, Núm. 8, pp. 980-989

  2. Neurocognitive Impairment in Patients Treated with Protease Inhibitor Monotherapy or Triple Drug Antiretroviral Therapy

    PLoS ONE, Vol. 8, Núm. 7

  3. Should we look for Strongyloides stercoralis in foreign-born HIV-infected persons?

    Journal of Immigrant and Minority Health, Vol. 15, Núm. 4, pp. 796-802

2012

  1. Características clínico-epidemiológicas de los pacientes inmigrantes con infección por el VIH: estudio de 371 casos

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 8, pp. 441-451

  2. Chagas disease screening among HIV-positive Latin American immigrants: An emerging problem

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 31, Núm. 8, pp. 1991-1997

2010

  1. Boosted protease inhibitor monotherapy. What have we learnt after seven years of research?

    AIDS Reviews, Vol. 12, Núm. 3, pp. 127-134

2009

  1. Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression

    Antiviral Therapy, Vol. 14, Núm. 2, pp. 195-201

2008

  1. Interpretación y consideraciones metodológicas y estadísticas en los estudios de rescate

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. SUPPL. 12, pp. 47-52

  2. Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression

    Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 6, pp. 1359-1361